Acrivon Therapeutics Inc
ACRV
Market Cap$217.11M
Close$
$0.11
91.7% downside
Current Fair Value
91.7% downsideOvervalued by 91.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $217.11 Million |
|---|---|
| Enterprise Value | $185.17 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.74 |
| Beta | 1.7 |
| Outstanding Shares | 36,132,616 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.67 |
|---|---|
| PEG | -18.95 |
| Price to Sales | - |
| Price to Book Ratio | 0.32 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.99 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data